05/16
Headlines

NASDAQ:AVNR

FB Nasdaq FB Facebook

Healthcare Gainers: BioScrip Inc (NASDAQ:BIOS), NPS Pharmaceuticals (NASDAQ:NPSP), RadNet Inc. (NASDAQ:RDNT), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

Richard Atkins02 mins

BioScrip Inc (NASDAQ:BIOS), on May 8, 2014 announced 2014 first quarter financial results. First quarter revenue from continuing operations was $239.6 million and the net loss from continuing operations was $25.4 million, or $0.37 per basic and diluted share. Non-GAAP adjusted loss from continuing operations per basic and diluted share was $0.13.BioScrip Inc (NASDAQ:BIOS) stock…

Read More

Healthcare bearish stocks: Intrexon Corp (NYSE:XON), Cynosure (NASDAQ:CYNO), Capital Senior Living Corporation (NYSE:CSU), Avanir Pharmaceuticals (NASDAQ:AVNR)

Jason Knox02 mins

Intrexon Corp (NYSE:XON) recently appointed James S. Turley. Mr. Turley’s effective direction of a global organization during some challenging economic times instilled the trust and confidence of key stakeholders, and Intrexon believes that his appointment to the Board as an independent director is in keeping with the best practices of corporate governance and providing guidance…

Read More

NASDAQ Volatile Stocks: Westport Innovations (NASDAQ:WPRT), Pharmacyclics (NASDAQ:PCYC), QLogic Corporation (NASDAQ:QLGC), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

Jayne Crisman02 mins

In trading on Thursday, shares of Westport Innovations, Inc.entered into oversold territory, hitting an RSI reading of 28.9, after changing hands as low as $12.71 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 58.2. A bullish investor could look at WPRT’s 28.9 RSI reading today as a sign…

Read More

Stocks to Watch: Horizon Pharma Inc (NASDAQ:HZNP), Avanir Pharmaceuticals (NASDAQ:AVNR), Catalyst Pharmaceutical Partners (NASDAQ:CPRX), Supernus Pharmaceuticals (NASDAQ:SUPN)

Chris Lewis02 mins

Specialist pharmaceutical company Horizon Pharma Inc (NASDAQ:HZNP) revealed on Thursday the receipt of Notice of Allowance for US Patent Application 13/713,528 entitled “Delayed-Release Tablet with Defined Core Geometry” that covers its US approved product RAYOS. Horizon Pharma Inc (NASDAQ:HZNP) stock performance was -7.89% in last session and finished the day at $12.02. Traded volume was…

Read More

Drugs Generic: Neurocrine Biosciences (NASDAQ:NBIX), The Medicines Company (NASDAQ:MDCO), Avanir Pharmaceuticals (NASDAQ:AVNR), Horizon Pharma (NASDAQ:HZNP)

Richard Atkins03 mins

Investors eyeing a purchase of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock, but tentative about paying the going market price of $14.27/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $11 strike, which has a bid at the time of…

Read More

Investors Watch List: Schlumberger Limited (NYSE:SLB), CafePress Inc. (NASDAQ:PRSS), Village Super Market Inc. (NASDAQ:VLGEA), Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR), Xylem Inc. (NYSE:XYL)

Kevin Long02 mins

Zacks reissued their neutral rating on shares of Schlumberger Limited. (NYSE:SLB) in a research report sent to investors on Monday morning. The firm currently has a $104.00 price target on the stock. Schlumberger Limited (NYSE:SLB) belongs to Basic Materials sector. Its net profit margin is 14.20% and weekly performance is -2.31%. On last trading day…

Read More